在体外心肺复苏后出血并发症的预测因素:SAVE-J II研究的见解
Madoka Sano1, Toshiaki Toyota1, Yoshinori Matsuoka2
1Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
JACC. Asia
|December 20, 2025
概括
身体外心肺复苏 (ECPR) 与出血风险有关,但心脏骤停的原因在调整后不会显著改变这些风险. 动脉内气球使用会增加出血,但降低死亡率.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 紧急医疗 紧急医疗
背景情况:
- 身体外心肺复苏 (ECPR) 是对耐心性心脏骤停的救生干预.
- 出血并发症是ECPR患者的一个重大问题,可能会影响结果.
- 了解与ECPR相关的出血风险对于患者管理至关重要.
研究的目的:
- 评估在接受外科心脏骤停 (OHCA) ECPR的患者中出血并发症的风险和预测因素.
- 根据OHCA病因 (内源性心脏病,内源性非心脏病,外源性) 对患者进行分层,并分析出血发生率.
- 确定与ECPR患者出血并发症和死亡率相关的因素.
主要方法:
- 在日本进行的SAVE-J II研究 (2013-2018) 的多中心数据分析.
- 对1935名OHCA患者的分层分为内源性心脏病,内源性非心脏病和外源性组.
- 评估的主要结果是ECPR后30天内发生的任何出血事件.
主要成果:
- 经过30天的累计出血发生率因OHCA原因而异 (25.9%内源性心脏,18.9%非心脏,13.7%外源性).
- 然而,调整后的出血风险在病因组之间没有显著差异.
- 动脉内气球使用与增加出血风险和降低全因死亡率有关.
结论:
- 在ECPR后,OHCA的根本原因不会显著影响调整后的出血风险.
- 动脉内气球抽独立地与较高的出血率和较低的死亡率有关,由于潜在的偏差,需要仔细解释.
- 在ECPR患者中,密切监测出血是必不可少的,特别是那些需要额外的循环支持的患者.
相关概念视频
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
267
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
267
01:30Acute Coronary Syndrome III: Diagnostic Studies
190
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
190
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
561
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
561
01:23Cardiopulmonary Resuscitation III: AED Use
473
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
473
01:21Cardiopulmonary Resuscitation I: Adult
526
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
526
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746